AI embryo selection
Software that scores or ranks embryos (often from time-lapse images) to help pick which to transfer.
Written by Fertility Decoded. Reviewed by D R, MS (OBG), FRM. Review date: 31 August 2026.
The verdict
Promising but unproven — not shown to improve your chance of a baby over standard embryo selection.
Who are these bodies?
- HFEA
- — UK fertility regulator; rates add-ons by evidence (traffic-light).
- ESHRE
- — European fertility society; evidence-based practice guidance.
- NICE
- — UK health-guidance body; what the NHS will and won't fund.
- ISAR
- — Indian Society for Assisted Reproduction; Indian expert consensus.
- Cochrane
- — Independent global reviewers of the underlying studies.
HFEA
UK regulator
Not on HFEA's rated list — chance of a babySourceESHRE
European society
Not covered (too new)Not covered in the 2023 ESHRE add-ons recommendations.
NICE
UK NHS guidance
Not addressedNot addressed in NG257.
ISAR
Indian society
No positionNot covered in the 2021 ISAR add-ons consensus.
Cochrane
Evidence base
Emerging technology; the largest prospective double-blind RCT (Illingworth 2024, iDAScore) did not beat standard morphology (46.5% vs 48.2% clinical pregnancy) and failed its non-inferiority margin.
Typical cost in India
Increasingly marketed, usually bundled with time-lapse; hard to price separately.
Sources
Take this further
Sources last reviewed .